Hong Ren-Hong
Key Laboratory Of Molecular Biology For Infectious Diseases
Chongqing, China
Chongqing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Waning humoral immune responses to inactivated SARS-CoV-2 vaccines in patients with severe liver disease.
Journal: Signal transduction and targeted therapy
Published: March 03, 2022
A systematic review with meta-analysis: Is ribavirin necessary in sofosbuvir-based direct-acting antiviral therapies for patients with HCV recurrence after liver transplantation?
Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
Published: March 05, 2019
Discovery of a polysaccharide from the fruiting bodies of Lepista sordida as potent inhibitors of indoleamine 2, 3-dioxygenase (IDO) in HepG2 cells via blocking of STAT1-mediated JAK-PKC-δ signaling pathways.
Journal: Carbohydrate polymers
Published: April 04, 2018
Circulating PD-1hiCXCR5+CD4+ T cells are associated with a decrease in hepatitis B surface antigen levels in patients with chronic hepatitis B who are receiving peginterferon-α therapy.
Journal: Molecular immunology
Published: April 01, 2018
Meta-analysis of randomized controlled trials of 4 weeks or longer suggest that curcumin may afford some protection against oxidative stress.
Journal: Nutrition research (New York, N.Y.)
Published: February 01, 2018
Baseline value of intrahepatic HBV DNA over cccDNA predicts patient's response to interferon therapy.
Journal: Scientific reports
Published: November 08, 2016
Serum hepatitis B virus RNA is encapsidated pregenome RNA that may be associated with persistence of viral infection and rebound.
Journal: Journal of hepatology
Published: November 28, 2015
A model with combined viral and metabolic factors effectively predicts HBeAg status under long term entecavir therapy: a prospective cohort study.
Journal: Virology journal
Published: August 27, 2015
Two-year results of a randomized, phase III comparative trial of telbivudine versus lamivudine in Chinese patients.
Journal: Hepatology international
Published: January 15, 2013
Treating chronic hepatitis B: what to do and how to do
Journal: Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology
Published: May 16, 2012
Strive for innovation and excellence
Journal: Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology
Published: April 11, 2012
New concepts about management for HBV drug resistance
Journal: Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology
Published: May 31, 2008
Last Updated: 09/26/2026